Revenue (Annual)

Revenue: The sum of all revenue fields included for a company's operating activities.

Starpharma Holdings Ltd. (SPHRY) had Revenue of $6.40M for the most recently reported fiscal year, ending 2024-06-30.

Quarterly Annual

Figures for fiscal year ending 2024-06-30

Income Statement Financials
Revenue	$6.40M
Net Income	$-5.35M
Cost of Goods Sold	$0.41M
Gross Profit	$5.98M
Operating Expenses	$11.75M
Operating Income	$-5.35M
Non-Operating Income/Expense	--
Pre-Tax Income	$-5.35M
Normalized Pre-Tax Income	$-5.35M
Income after Taxes	$-5.35M
Income from Continuous Operations	$-5.35M
Consolidated Net Income/Loss	$-5.35M
Normalized Income after Taxes	$-5.35M
EBIT	$-5.35M
EBITDA	$-4.62M
Weighted-Average Shares Outstanding (Basic)	41.14M
Weighted-Average Shares Outstanding (Diluted)	41.14M
Earnings per Share (EPS) (Basic)	$-0.13
Earnings per Share (EPS) (Diluted)	$-0.13
Balance Sheet Financials
Current Assets	$21.59M
Property, Plant, and Equipment	$0.86M
Long-Term Assets	$2.55M
Total Assets	$24.14M
Current Liabilities	$4.37M
Long-Term Debt	$1.28M
Long-Term Liabilities	$1.34M
Total Liabilities	$5.70M
Common Equity	$18.44M
Tangible Shareholders Equity	$18.44M
Shareholders Equity	$18.44M
Common Shares Outstanding	41.24M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$-4.58M
Cash Flow from Investing Activities	$-0.06M
Cash Flow from Financial Activities	$-3.11M
Beginning Cash	$23.07M
End Cash	$15.32M
Increase/Decrease in Cash	$-7.75M
Stock-Based Compensation	--
Common Stock Dividends Paid	--
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	4.94
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	0.07
Debt to Equity Ratio	0.13
Gross Margin	93.52%
Operating Margin	-83.69%
EBIT Margin	-83.69%
EBITDA Margin	-72.26%
Pre-Tax Profit Margin	-83.69%
Profit Margin	-83.69%
Free Cash Flow	$-4.63M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.27
Inventory Turnover	0.26
Receiveable Turnover	1.36
Days Sales in Receivables	267.54
Return on Equity	-29.04%
Return on Tangible Equity	-29.04%
Return on Assets	-22.18%
Return on Investments	-27.15%
Book Value Per Share	$0.45
Free Cash Flow per Share	$-0.11
Operating Cash Flow per Share	$-0.11

Data from Zacks Investment Research, Inc.